{
    "2018-01-02": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：近几年我国医药产业创新环境的变化",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "创新环境"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-01",
                "original_text": "医药行业2018年1月份投资月报:2018的“2+2”医药投资策略",
                "features": {
                    "keywords": [
                        "医药",
                        "投资策略",
                        "2+2"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018",
                "original_text": "医药行业2018年投资策略：正本清源柳暗花明",
                "features": {
                    "keywords": [
                        "医药",
                        "投资策略",
                        "正本清源"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业:首批一致性品种出台,看好后续投资机会",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "一致性品种",
                        "投资机会"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "【医药】江琦：医药生物行业2018年1月月报：2018是政策落地大年，看好创新药、高品质仿制药、医疗服务三大方向-增持-0101",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "政策落地",
                        "创新药",
                        "仿制药",
                        "医疗服务"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}